Source: BusinessWire 

Mars, Incorporated is in exclusive talks to acquire Cerba HealthCare’s stakes in Cerba Vet and ANTAGENE, aiming to expand its Veterinary diagnostics sector. Cerba Vet, located in France and Switzerland, specializes in a comprehensive range of Veterinary diagnostic services and is renowned for its educational initiatives through Cerba Vet College.

ANTAGENE, based in Lyon, France, is a leader in DNA testing for animals across Europe, contributing to disease diagnosis and biodiversity preservation. This potential acquisition would complement Mars’ existing Veterinary diagnostics business, Antech. Mars Science & Diagnostics, under President Nefertiti Greene, looks forward to enhancing R&D and services to improve animal health outcomes. The acquisition is pending employee consultations and customary closing conditions.

Read the full story HERE: